Malignant Lip and Oral Cavity Neoplasm — Trials

Malignant Lip and Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 149
Recruiting: 77
Ph III recruiting: 11
Growth YoY: +4.8%
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03684707	Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions	unknown	Phase 4	30	Ain Shams UniversityOTHER	1	Sep 26, 2018	clinicaltrials
NCT03017053	The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor	unknown	Phase 4	270	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER	1	Jan 11, 2017